Eden BioSolutions plc (FRA:9T7)
Germany · Delayed Price · Currency is EUR | Market Cap | 22.33M +45.7% |
| Revenue (ttm) | 4.45M -5.8% |
| Net Income | -2.24M |
| EPS | -0.00 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 9,000 |
| Open | 0.0175 |
| Previous Close | 0.0230 |
| Day's Range | 0.0175 - 0.0230 |
| 52-Week Range | 0.0150 - 0.0495 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 18, 2026 |
About Eden BioSolutions
Eden BioSolutions plc, together with its subsidiaries, biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health, and consumer products industries in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consumer products, such as head-lice treatment, deodorants, odour neutralizer, an... [Read more]
Financial Performance
In fiscal year 2026, Eden BioSolutions's revenue was 3.88 million, a decrease of -9.78% compared to the previous year's 4.30 million. Losses were -1.96 million, 2.67% more than in 2024.
Financial numbers in GBP Financial StatementsNews
AIM Market Roundup: Zenova, CAP-XX, Eden Research
Zenova, CAP-XX, Eden Research are today's top risers, while Revolution Beauty, Arkle Resources take the biggest fall on London's AIM market